Martin Westphal,Silke Baasner,Stefanie HONNDORF,Edmundo BRITO DE LA FUENTE,Crispulo Gallegos-Montes,Lida Quinchia-Bustamante
申请号：
US16483730
公开号：
US20200022941A1
申请日:
2018.02.06
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the treatment of liver diseases. In particular, it relates to a composition for use in treating and/or preventing a liver disease in a subject, wherein said composition comprises eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) wherein the ratio of EPA to DHA is at least 2:1.
